Dr. Alfin G. Vicencio is the Chief of the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and the Kravis Children's Hospital at Mount Sinai. After completing his undergraduate studies at the University of Notre Dame and obtaining his medical degree from the University of Toledo, he relocated to the East Coast, where he completed a pediatric residency at Babies and Children's Hospital (Columbia University) and a pediatric pulmonology fellowship at Yale University. A primary clinical interest of his over the past several years has been severe and refractory asthma. Together with several regional collaborators, Dr. Vicencio is helping to identify patients who may have sub-clinical fungal infection in the lower airway as a cause of persistent symptoms, as well as formulate new diagnostic and treatment plans for such patients. In addition to his work in asthma, he has extensive experience in diagnostic and interventional flexible bronchoscopy in children, including visual examination of the airways, bronchoalveolar lavage, endo- and transbronchial biopsy, foreign body retrieval, balloon dilation, and other therapeutic procedures. Such procedures are performed in a state-of-the-art bronchoscopy suite, where he works closely with members of the adult interventional bronchoscopy service, including Dr. Timothy Harkin. Dr. Vicencio has published on a variety of topics including asthma, flexible bronchoscopy, wheezing, tracheobronchomalacia, bronchiolitis and bronchopulmonary dysplasia, and has been recognized as a "Top Doctor" both regionally and nationally.
MD, Medical College of Ohio Hospital
New York Presbyterian Hospital
Yale University School of Medicine
Vicencio A, Santiago M, Tsirialkis K, Stone A, Worgall S, Foley E, Bush D, Casadevall A, Goldman D. Fungal sensitization in childhood persistent asthma is associated with disease severity. . Pediatric Pulmonology, in press.;.
Goldman D, Vicencio A. The chitin connection. . mBio 2012; 3(2): e00056-12. .
Goldman D, Li X, Tsirilakis K, Andrade C, Casadevall A, Vicencio A. Increased chitinase expression and fungal specific antibodies in the bronchoalveolar lavage fluid of asthmatic children. . Clinical and Experimental Allergy 2011 October;.
Patel K, Vicencio A, Salva P, Tsirilakis K, Du Z, Webley W. Chlamydia pneumoniae is associated with elevated IL-8 and airway neutrophilia in children with refractory asthma. . Ped Infect Dis J. 2010 December; 29(12): 1093-8.
Vicencio A, Chupp G, Tsirilakis K, Kessel A, Nandalike K, Veler H, Kipperman S, Young M, Goldman D. CHIT1 mutations: A genetic risk factor for severe asthma with fungal sensitization?. Pediatrics 2010 October; 126(4): e982-5.
Nandalike K, Kessell A, Tripati S, Sweberg T, Vicencio A. Foreign body aspiration in a child with unilateral lung aplasia.. Pediatric Critical Care Medicine 2010 July;.
Vicencio A, Bent J, Tsirilakis K, Nandalike K, Veler H, Parikh S. Management of severe tracheal stenosis using flexible bronchoscopy and impulse oscillometry. . Journal of Bronchology & Interventional Pulmonology 2010 April; 17(2): 162-164.
Vicencio A, Narain S, Du Z, Zeng W, Ritch J, Casadevall A, Goldman D. Pulmonary cryptococcosis induces chitinase in the rat. . Respiratory Research 2008 May; 15(9): 40.
Vicencio A, Needleman J. Evaluation of the child with recurrent wheezing. . In: Pediatric Primary Care 5th Ed. . Elk Grove Village, IL, Elsevier;.
Vicencio A, Bent J. Evaluation of stridor. . In: Pediatric Primary Care 5th Ed. . Elk Grove Village, IL, Elsevier;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Vicencio did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.